Whether APOE genotype also differentially modulates degree of Aβ plaque load reduction in response to anti-Aβ passive immunization remains unknown due to limited clinical data and because preclinical testing of anti-Aβ mAbs has been exclusively conducted in AD transgenic (Tg) mice models expressing wild type, murine apoE [9–12]. This evidence concerns the gene APOE and Alzheimer disease.